Shanghai Zerun Biotechnology Co Ltd - Company Review
Shanghai Zerun Biotechnology Co Ltd - Company ReviewSummary
Shanghai Zerun Biotechnology Co Ltd (ZeRun biological), a subsidiary of Walvax Biotechnology Co Ltd is a biotechnology company that develops, manufactures and commercializes novel vaccines. The company’s products include vero cell-based hepatitis A vaccine, and prophylactic cervical cancer vaccine. It also develops traditional prophylactic vaccines; VLP based recombinant prophylactic vaccines; and other therapeutic vaccines. ZeRun biological conducts research on vaccines developed through traditional technology. The company owns and operates manufacturing plant in China for engineering and process development and for the production of the vaccine bulk and fill finish process. It operates through various domestic and international academic institutions, global health organizations and vaccine industry partners. Zerun Biotech is headquartered in Shanghai, China.
This comprehensive company report of Shanghai Zerun Biotechnology Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.